BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Feb 26, 16:00
BioInvent International EPS Diluted (Quarterly) : -0.2063 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -- |
| Hansa Biopharma AB | -0.1724 |
| BioArctic AB | -0.0106 |
| BioGaia AB | 0.1038 |
| Camurus AB | 0.1778 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.58M |
| Revenue (Quarterly) | 0.3489M |
| Total Expenses (Quarterly) | 13.93M |
| Enterprise Value | 144.13M |
| Profit Margin (Quarterly) | -3.89K% |
| Earnings Yield | -14.48% |
| Normalized Earnings Yield | -14.48 |